Intellia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 890 | 0.0% | 99,006 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,548 | 0.0% | 89,630 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 841 | 0.0% | 89,625 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 644 | 0.0% | 90,638 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,057 | 0.0% | 90,638 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,789 | 0.0% | 87,042 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 2,011 | 0.0% | 89,851 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 2,353 | 0.0% | 85,531 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 2,726 | 0.0% | 89,400 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 2,834 | 0.0% | 89,613 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 4,039 | 0.0% | 99,054 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 3,468 | 0.0% | 93,054 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 3,261 | 0.0% | 93,455 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 4,954 | 0.0% | 88,522 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,625 | 0.0% | 89,360 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 6,320 | 0.0% | 86,973 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 11,108 | 0.0% | 93,941 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 11,730 | 0.0% | 87,436 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 14,255 | 0.0% | 88,044 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 6,641 | 0.0% | 82,746 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 4,125 | 0.0% | 75,834 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 1,508 | 0.0% | 75,834 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 1,389 | 0.0% | 66,085 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 714 | 0.0% | 58,392 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 884 | 0.0% | 60,244 | 12/31/2019 |